Binax® Legionella Urinary Antigen EIA

GUDID 10811877010460

For the qualitative detection of Legionella pneumophila serogroup 1 antigen in human urine.

Alere Scarborough, Inc.

Legionella pneumophila antigen IVD, kit, enzyme immunoassay (EIA)
Primary Device ID10811877010460
NIH Device Record Key6d88293b-e714-46a7-a7ec-bc7de30bc3fd
Commercial Distribution StatusIn Commercial Distribution
Brand NameBinax® Legionella Urinary Antigen EIA
Version Model Number851-000
Company DUNS154148498
Company NameAlere Scarborough, Inc.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS110811877010460 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

MJHLegionella, Spp., Elisa

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number3
Public Version Date2023-09-12
Device Publish Date2016-09-03

Devices Manufactured by Alere Scarborough, Inc.

00811877012030 - BinaxNOW COVID-19/Flu A&B Combo Self Test2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens
00811877012047 - BinaxNOW COVID-19/Flu A&B Combo Self Test2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens
00811877012054 - BinaxNOW COVID-19/Flu A&B Combo Self Test2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens
00811877012061 - BinaxNOW COVID-19/Flu A&B Combo Self Test2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens
00811877012078 - BinaxNOW COVID-19/Flu A&B Combo Self Test2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens
00811877012085 - BinaxNOW COVID-19/Flu A&B Combo Self Test2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens
00811877012092 - BinaxNOW COVID-19/Flu A&B 2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens
00811877012108 - BinaxNOW COVID-19/Flu A&B Controls2025-02-07 Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens

Trademark Results [Binax]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BINAX
BINAX
79154972 4706031 Live/Registered
Sivantos Pte. Ltd.
2014-07-11
BINAX
BINAX
76225455 2651349 Dead/Cancelled
ALERE SCARBOROUGH, INC.
2001-03-16
BINAX
BINAX
73271144 1251065 Dead/Cancelled
Central Plants, Inc.
1980-07-21

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.